Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Reduced by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,477 shares of the biotechnology company’s stock after selling 2,175 shares during the period. Mutual of America Capital Management LLC’s holdings in Axon Enterprise were worth $6,227,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Public Sector Pension Investment Board boosted its position in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares in the last quarter. CIBC Asset Management Inc grew its position in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares in the last quarter. Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise in the third quarter worth $814,000. Soros Capital Management LLC purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $630,000. Finally, Friedenthal Financial raised its position in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after acquiring an additional 1,231 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Down 0.5 %

Shares of AXON opened at $525.75 on Tuesday. The firm has a market capitalization of $40.09 billion, a price-to-earnings ratio of 135.85, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business’s fifty day moving average price is $607.58 and its two-hundred day moving average price is $526.43.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,407 shares of company stock worth $4,122,925 over the last 90 days. Insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of several recent research reports. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC reissued a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Finally, Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.